|
|
News Breaks | | | | October 16, 2012 | | 07:07 EDT |  | ARWR | ArrowHead Research receives allowance for patent for DPC
Arrowhead Research announced that it received a Notice of Allowance from the U.S. Patent and Trademark Office, or USPTO, for patent application U.S. 13/032,029 entitled, " Compositions for Targeted Delivery of siRNA." The patent broadly covers compositions, methods, and uses for a new formulation of Arrowhead's Dynamic Polyconjugate, or DPC, siRNA delivery platform, where attachment of siRNA and delivery vehicle is not required to produce high-level, efficient knockdown of target genes. The new IP expands the DPC platform and is used in Arrowhead's ARC-520 candidate in development for chronic hepatitis B virus infection. | |
|
News For ARWR From The Last 14 Days Check below for free stories on ARWR the last two weeks. |
|
|
| May 13, 2013 | | 16:39 EDT | | ARWR | Sabby reports 6.99% passive stake in ArrowHead Research
| | | May 9, 2013 | | 17:19 EDT | | ARWR | RA Capital reports 9.9% passive stake in ArrowHead Research
 Subscribe for More Information | | | 16:45 EDT | | ARWR | Camber Capital reports 9.9% passive stake in ArrowHead Research
| |
|
|
|
|
|
|
